MAIN ARTICLE
A crackdown measured in hundreds of advertisements
On November 16, the Ministry of Food and Drug Safety (MFDS) released the results of its October 26–30 checks of social media and other websites. Inspectors identified 571 instances of unlawful online medicine sales, brokering or promotion ahead of the Suneung examination scheduled for November 19. According to Yonhap and The Korea Times, regulators requested access restrictions from the relevant authorities. Crucially, 571 refers to posts detected, not the number of students who bought or used the medicines. That distinction matters when assessing both the scale of enforcement and the limits of what the findings establish.
The largest category comprised 553 posts offering methylphenidate under attractive labels such as “concentration medicine.” Another 18 involved propranolol or similar prescription products sold as solutions to test nerves or job-interview anxiety. MFDS said monitoring campaigns during the year had identified 2,536 illegal online posts involving methylphenidate by the end of October. This suggests a recurring marketing tactic; it does not, by itself, establish how common non-medical consumption is among applicants.














